← Eichor
Condition: Prosthetic Joint Infections Of Hip Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Prosthetic Joint Infections Of Hip

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Long Term Follow-up of Patients With Prosthetic Joint Infection of the Hip Treated at University Hospitals Leuven
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05000723Periprosthetic Joint Infections: Diagnostic Accuracy and Cost-effectiveness Analysis of Serum and Synovial Markers
Phase N/A · 1 location(s) · Istituto Ortopedico Rizzoli · NCT04858217The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of th
NA · 1 location(s) · NYU Langone Health · NCT06919913ROADMAP Clinical Trial
Phase 4 · 43 location(s) · University of Newcastle, Australia · NCT06771050Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Revision Hip Prosthesis System
Phase N/A · 4 location(s) · TIPMED Medical Device Manufacturing Ltd. Co. · NCT07653295CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee
NA · 3 location(s) · Sunnybrook Health Sciences Centre · NCT05828810IP-coated Revision Hip Implants
NA · 2 location(s) · Aesculap AG · NCT06737809Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
Phase 4 · 13 location(s) · Leiden University Medical Center · NCT06172010
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.